Juno Bio, a pioneer in the women’s health technology sector, has announced the successful closure of a $3.8 million funding round, a financial milestone that facilitates the launch of the first-ever CLIA-certified sequencing laboratory dedicated exclusively to the vaginal microbiome. This strategic move, announced on Thursday, represents a significant leap forward in the clinical infrastructure […]
The American Medical Association’s latest National Physician Comparison Report indicates a significant shift in the landscape of healthcare professional well-being, revealing that aggregate physician burnout has fallen for the third consecutive year, reaching approximately 41.9% in 2025. This figure represents a notable decline from the 48.2% recorded in 2023 and the pandemic-era peaks that saw […]
The landscape of American primary care is undergoing a seismic shift as private equity firms increasingly pivot toward membership-based models, including Concierge medicine and Direct Primary Care (DPC). While the "entry story"—the initial acquisition and infusion of capital—has been widely documented and celebrated by proponents of market-driven healthcare, the "exit story" remains largely untold. As […]
The Centers for Medicare & Medicaid Services (CMS) has unveiled its proposed rule for the 2027 Medicare Physician Fee Schedule (MPFS), signaling a transformative shift in how the federal government compensates healthcare providers for digital health services. Among the most consequential updates are sweeping changes to the reimbursement framework for Remote Patient Monitoring (RPM) and […]
The House Ways and Means Committee achieved a rare moment of bipartisan consensus on Wednesday, voting 42-0 to advance the Improving Seniors’ Timely Access to Care Act, a legislative package designed to overhaul the prior authorization process within the Medicare Advantage (MA) program. The bill, which has been a primary focus for healthcare advocacy groups […]
Eli Lilly and Company has announced a definitive agreement to acquire AtaiBeckley, a clinical-stage biotechnology firm specializing in psychedelic-based therapies, in a deal valued at approximately $2.8 billion in upfront cash. This strategic move signals a significant expansion of Lilly’s neuroscience portfolio, positioning the pharmaceutical giant as a major contender in the rapidly evolving field […]
The digital health sector has demonstrated significant resilience and strategic maturation in the first half of 2026, securing $7.4 billion in venture capital funding. This figure represents a notable 15.6% increase from the $6.4 billion raised during the same period in 2025, signaling a robust recovery and a more disciplined approach to capital allocation within […]
The healthcare industry is currently navigating a period of profound transformation, characterized by a dual focus on technological integration and fiscal discipline. As the sector moves further into the mid-2020s, the traditional boundaries between payers, providers, and technology firms continue to blur. This evolution is reflected in the latest wave of executive appointments and organizational […]
Avalyn Pharma has successfully transitioned to the public markets, raising $300 million in an initial public offering that significantly exceeded initial expectations. The Boston-based biotechnology company, which specializes in developing inhaled versions of established treatments for life-threatening lung diseases, priced its offering at the top of its targeted range, signaling robust investor confidence in its […]
The uneasy truce between Shah Capital and Novavax has officially fractured, signaling a high-stakes showdown at the vaccine maker’s upcoming 2026 Annual Meeting. Himanshu Shah, founder and managing partner of the North Carolina-based hedge fund, has formally notified the Novavax board of directors of his firm’s intent to vote against the re-election of current board […]
